Inova Translational Medicine Institute (ITMI)
Research facility
Location:
Annandale,
United States (USA) (US)
miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate (2019)
Ji Y, Fioravanti J, Zhu W, Wang H, Wu T, Hui J, Lacey NE, et al.
Journal article
The transcription factor c-Myb regulates CD8+T cell stemness and antitumor immunity (2019)
Gautam S, Fioravanti J, Zhu W, Le Gall JB, Brohawn P, Lacey NE, Hu J, et al.
Journal article